Welcome to Gentronix

Gentronix provides services and solutions to help organisations optimise the development of drugs and other chemicals, by reducing attrition due to toxicity thus ensuring safer products across a wide range of chemistry driven industries.

We provide contract  services for genotoxicity using our patented human cell GADD45a reporter  GreenScreen HC® and BlueScreen HC™ assays and related assays including Micronucleus and Ames MPF™.

Get answers

Latest News

GreenScreen and BlueScreen to be discussed in IWGT Plenary Session

The 4-yearly International Workshops on Genotoxicity Testing (IWGT) will again be held as a satellite to the International Conference on…

Read the story Read all news

Highlights

New Paper Sheds Light on Role of WT1 Protein in p53-Dependent and p53-Independent Pathways for GADD45a Regulation A new paper by Gentronix researchers, published in the journal Mutagenesis, increases our understanding of why the GADD45a gene has…

New BlueScreen HC Publication from GSK GlaxoSmithKline researchers have published a paper describing the miniaturisation and automation of the BlueScreen HC assay for use with 384 well plates.

Follow us on Twitter Gentronix is now on Twitter. For the latest news and information on early genetic toxicology screening and mechanistic follow up…